ImmusanT, Inc.
CAMBRIDGE, MA · Founded 2010 · CIK 0001538991 · Biotech · Defunct
Epitope-specific immunotherapy platform to induce immune tolerance in autoimmune diseases
immusant.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $33M
- 2 Form D · Nov 2017
- 107 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 4 granted · 36 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $12,777,407 | |
| Private capital raised | Form D · SEC | $19,875,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2455 | Plexium | — | $60M |
| 2456 | Prolific Machines | — | $55M |
| 2457 | LIFESPLICE PHARMA, LLC | — | — |
| 2458 | ImmusanT, Inc. | — | $33M |
| 2459 | GALECTIN THERAPEUTICS INC | — | $6.8M |
| 2460 | Eidos Therapeutics | — | $26M |
| 2461 | Expesicor Inc | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Thomas DanielDirector
- Craig EstwickDirector
- Kevin FerroDirector
- Steven GillisDirector
- Ceclia GonzaloDirector
- Sundar KodiyalamDirector
- Thomas KoestlerDirector
- Justin SunDirector
- Leslie WilliamsDirector · Executive Officer
Patents
- Compositions And Methods For Treatment Of Celiac Diseaseapplication
- Dosing Regimens For Celiac Diseaseapplication
- Peptides For Use In Treatment And Diagnosis Of Type 1 Diabetesapplication
- Use Of Hla Genetic Status To Assess Or Select Treatment Of Celiac Diseaseapplication
- Peptides For Use In Treatment And Diagnosis Of Type 1 Diabetesgranted
- Dosage Of A Gluten Peptide Compositiongranted
- Use Of Hla Genetic Status To Assess Or Select Treatment Of Celiac Diseasegranted
- Escalating Dosage Schedules For Treating Celiac Diseaseapplication
- Compositions And Methods For Diagnosing Celiac Disease Using Circulating Cytokines/chemokinesapplication
- Compositions And Methods For Treatment Of Celiac Diseaseapplication
- Methods Of Diagnosis And Treatment Of Celiac Disease In Childrenapplication
- Compositions And Methods For Treatment Of Celiac Diseaseapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.